Literature DB >> 28802157

Droplet digital PCR for rapid enumeration of viral genomes and particles from cells and animals infected with orthopoxviruses.

Jeffrey L Americo1, Patricia L Earl1, Bernard Moss2.   

Abstract

Droplet digital polymerase chain reaction (ddPCR) was adapted for quantifying the number of orthopoxviral genomes in purified virus samples, infected cell lysates and tissues of infected animals. In contrast to the more commonly used qPCR, the newer ddPCR provides absolute numbers of DNA copies in samples without need for standard curves and has the ability to detect rare mutants in a population. The genome/infectious unit ratio for several sucrose gradient-purified orthopoxviruses varied from 5 to 10, which correlated well with values obtained using the Virocyt, a dedicated fluorescence flow cytometer. By employing a nuclease step to digest unencapsulated DNA, the genome/infectious unit ratios of virus in crude cell lysates approached that of purified virus particles. The speed, accuracy, sensitivity, and dynamic range of less than one to millions of infectious units in a sample make this semi-automated method well suited to a variety of laboratory, animal and clinical studies.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Digital droplet polymerase chain reaction; Poxvirus particle infectivity ratio; Poxvirus quantification; Vaccinia virus quantification

Mesh:

Year:  2017        PMID: 28802157      PMCID: PMC5623639          DOI: 10.1016/j.virol.2017.08.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Evaluation of the Virus Counter® for rapid baculovirus quantitation.

Authors:  Matthew M Ferris; Patricia C Stepp; Kirk A Ranno; Wafaa Mahmoud; Elizabeth Ibbitson; James Jarvis; Manon M J Cox; Kurt Christensen; Heather Votaw; Dean P Edwards; Kathy L Rowlen
Journal:  J Virol Methods       Date:  2010-10-21       Impact factor: 2.014

3.  Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.

Authors:  Patricia L Earl; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Sib selection.

Authors:  M McCormick
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Orthopoxvirus infection among wildlife in Zambia.

Authors:  Yasuko Orba; Michihito Sasaki; Hiroki Yamaguchi; Akihiro Ishii; Yuka Thomas; Hirohito Ogawa; Bernard M Hang'ombe; Aaron S Mweene; Shigeru Morikawa; Masayuki Saijo; Hirofumi Sawa
Journal:  J Gen Virol       Date:  2014-10-15       Impact factor: 3.891

6.  Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus.

Authors:  Victoria A Olson; Thomas Laue; Miriam T Laker; Igor V Babkin; Christian Drosten; Sergei N Shchelkunov; Matthias Niedrig; Inger K Damon; Hermann Meyer
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Chasing Jenner's vaccine: revisiting cowpox virus classification.

Authors:  Darin S Carroll; Ginny L Emerson; Yu Li; Scott Sammons; Victoria Olson; Michael Frace; Yoshinori Nakazawa; Claus Peter Czerny; Morten Tryland; Jolanta Kolodziejek; Norbert Nowotny; Melissa Olsen-Rasmussen; Marina Khristova; Dhwani Govil; Kevin Karem; Inger K Damon; Hermann Meyer
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

8.  Absolute quantification by droplet digital PCR versus analog real-time PCR.

Authors:  Christopher M Hindson; John R Chevillet; Hilary A Briggs; Emily N Gallichotte; Ingrid K Ruf; Benjamin J Hindson; Robert L Vessella; Muneesh Tewari
Journal:  Nat Methods       Date:  2013-09-01       Impact factor: 28.547

9.  Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes.

Authors:  Anna-Theresa Lülf; Astrid Freudenstein; Lisa Marr; Gerd Sutter; Asisa Volz
Journal:  Virology       Date:  2016-10-11       Impact factor: 3.616

10.  A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.

Authors:  Laura Hughes; Kimberly Wilkins; Cynthia S Goldsmith; Scott Smith; Paul Hudson; Nishi Patel; Kevin Karem; Inger Damon; Yu Li; Victoria A Olson; P S Satheshkumar
Journal:  J Virol Methods       Date:  2017-01-26       Impact factor: 2.623

View more
  7 in total

1.  Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.

Authors:  Tatiana G Senkevich; Erik K Zhivkoplias; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

3.  Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins.

Authors:  Andrew I Tak; Jeffrey L Americo; Ulrike S Diesterbeck; Bernard Moss
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

4.  Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.

Authors:  Lalita Priyamvada; Wouter W Kallemeijn; Monica Faronato; Kimberly Wilkins; Cynthia S Goldsmith; Catherine A Cotter; Suany Ojeda; Roberto Solari; Bernard Moss; Edward W Tate; Panayampalli Subbian Satheshkumar
Journal:  PLoS Pathog       Date:  2022-10-10       Impact factor: 7.464

5.  Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation.

Authors:  Ruikang Liu; Lisa R Olano; Yeva Mirzakhanyan; Paul D Gershon; Bernard Moss
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.423

6.  Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022.

Authors:  Nir Paran; Yfat Yahalom-Ronen; Ohad Shifman; Shirley Lazar; Ronen Ben-Ami; Michal Yakubovsky; Itzchak Levy; Anat Wieder-Feinsod; Sharon Amit; Michal Katzir; Noga Carmi-Oren; Ariela Levcovich; Mirit Hershman-Sarafov; Alona Paz; Rebecca Thomas; Hadas Tamir; Lilach Cherry-Mimran; Noam Erez; Sharon Melamed; Moria Barlev-Gross; Shay Karmi; Boaz Politi; Hagit Achdout; Shay Weiss; Haim Levy; Ofir Schuster; Adi Beth-Din; Tomer Israely
Journal:  Euro Surveill       Date:  2022-09

7.  Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.

Authors:  Chen Peng; Linda S Wyatt; Shira G Glushakow-Smith; Madhu Lal-Nag; Andrea S Weisberg; Bernard Moss
Journal:  PLoS Pathog       Date:  2020-08-31       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.